Home › Type 2 Diabetes › District of Columbia
Type 2 Diabetes clinical trials in District of Columbia
7 studies for Type 2 Diabetes are looking for participants at sites in District of Columbia.
Cities in District of Columbia
The RESET System Pivotal Clinical Trial (Protocol Revision H)
- MedStar Health Research Institute, Washington D.C.
Recruiting
Ages 22 to 65 · All sexes · Updated Oct 5, 2026 · NCT04101669Plant-Based Online Weight Loss Through Education and Resources Program and Study
- Physicians Committee for Responsible Medicine, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07095543Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- Children's National Hospital (CNH), Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 12 to 25 · All sexes · Updated Sep 17, 2026 · NCT06730113A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Emerson Clinical Research Institute, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Emerson Clinical Research Institute, Washington D.C.
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122Diabetes Reversal Online Program and Study (DROP Study)
- Physician Committee for Responsible Medicine, Washington D.C.
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 18, 2024 · NCT05572502From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.